AKT1 and glioblastoma: Previous studies have also demonstrated a strong link between HSPD1 and the AKT/mTOR pathway, e.g., HSPD1 silencing-mediated inactivation of the mTOR pathway inhibited the progression of glioblastoma and CRC 57, 58.